A significant rise in whooping cough, or pertussis, is being observed across the Netherlands, particularly among children and adolescents, following the easing of COVID-19 restrictions. Recent data from the National Institute for Public Health and the Environment (RIVM) indicates that approximately one in three children between the ages of 6 and 18 may have been infected with whooping cough since the pandemic began to subside. This resurgence highlights the importance of vaccination and awareness of the disease, even as immunity wanes over time.
The sharp increase in cases is largely attributed to the reduced spread of respiratory illnesses during the pandemic, when measures like social distancing, mask-wearing, and school closures were in place. These measures inadvertently limited exposure to whooping cough, leading to a decrease in natural immunity within the population. As restrictions lifted in 2022, the highly contagious bacterial infection began to circulate more freely, especially among those who were not recently boosted or had waning immunity from earlier vaccinations. Understanding the dynamics of whooping cough transmission is crucial for public health officials.
Whooping Cough: Symptoms and Impact on Children
Even as many infections are mild, presenting with cold-like symptoms, whooping cough can be serious, particularly for infants. The characteristic “whooping” sound comes from the desperate gasps for air after a fit of violent coughing. According to the RIVM’s research, conducted between November 2022 and October 2024, 6.3 percent of people in the Netherlands, aged 2 to 87, showed evidence of recent infection through antibody testing. However, among those aged 6 to 18, the infection rate was considerably higher. Notably, around 16 percent of those infected experienced prolonged coughing, which can significantly disrupt daily life and require medical attention.
The illness begins like a common cold, with a runny nose, mild fever, and a cough. However, after one to two weeks, the cough worsens, progressing into severe coughing fits followed by a high-pitched “whoop” sound as the individual inhales. These coughing fits can be exhausting and can lead to complications such as pneumonia, bronchitis, and, in rare cases, neurological issues. Young infants are particularly vulnerable, as they may not be able to cough effectively to clear their airways.
The Role of Vaccination and Current Protection Levels
The Netherlands has included whooping cough vaccination in its National Immunisation Programme since 1957. Recent adjustments to the vaccination schedule aim to provide even better protection for children. The RIVM’s research confirms that vaccination remains highly effective in preventing severe cases of whooping cough. However, the study also demonstrates that immunity from the vaccine isn’t lifelong, and the disease can circulate within the population even among vaccinated individuals.
The current vaccine used in the Netherlands is a combination vaccine that protects against diphtheria, tetanus, polio, and whooping cough (DTaP-IPV). Booster vaccinations are recommended throughout life, particularly for pregnant women in the third trimester of each pregnancy. This provides passive immunity to the newborn infant, who is most at risk of severe complications from whooping cough before they can be vaccinated themselves.
What to Do If You Suspect Whooping Cough
Currently, there is no specific treatment for whooping cough, but antibiotics can be prescribed, particularly if administered early in the course of the illness. Antibiotics can help reduce the severity of symptoms and limit the spread of the infection. Supportive care, such as rest, fluids, and monitoring for complications, is also essential.
If you or your child develop a persistent cough, especially one accompanied by a “whooping” sound, This proves crucial to consult a doctor. Early diagnosis and treatment can help prevent complications and protect others from infection. Public health officials emphasize the importance of reporting suspected cases to help track the spread of the disease and implement appropriate control measures.
The RIVM continues to monitor whooping cough cases and provide updated information and guidance to healthcare professionals and the public. Staying informed about vaccination schedules and recognizing the symptoms of whooping cough are key steps in protecting yourself and your community. The agency is also investigating the potential impact of waning immunity and the effectiveness of current vaccination strategies.
Looking ahead, the RIVM will continue to analyze data on whooping cough incidence and vaccination coverage to inform future public health recommendations. The next update on the national vaccination program is scheduled for release in early 2025. We encourage readers to share this information and discuss any concerns with their healthcare providers.
